Recording Date: May 30th
Presenter: Michelle Moore, Natasha Petry, and Jordan Baye, Sanford Imagenetics

Summary of Webinar

Sanford Imagenetics will present implementation strategies for a large-scale rural based pharmacogenomics program focused on pre-emptive testing bringing together internal medicine and primary care medicine with genetics. They describe a unique interdisciplinary team including a variety of roles—pharmacists, geneticists, lab scientists, and genetic counselorsfor the program that spans nine states. They will discuss some of the obstacles the team encountered and how they were able to overcome them.

By attending this webinar, audience members will be able to:

  • Describe the components to implementing pharmacogenomics in a large rural healthcare system
  • Understand the roles different healthcare professionals have in an integrated precision medicine program
  • List different steps to provide education in pharmacogenomics and precision medicine to multiple healthcare professionals
  • Discuss barriers to implementing precision medicine over a large geographic footprint


About the Presenters

michelle-mooreMichelle Moore, MS, LCGC is an experienced genetic counselor who is part of Sanford Imagenetics as a senior laboratory genetic counselor. She has experience in laboratory, genomic medicine, prenatal, cancer, pediatric, adult, and metabolic genetics in both the United States and Great Britain. She is actively involved in the National Society of Genetic Counselors as a contributing member to many of the organizations special interest groups (SIG) and was a previous member of the NSGC ethics committee and previous chair of the CTD SIG. She has a special interest in skeletal dysplasias, having been on the Little People of America’s medical advisory board from 2005 to 2017.


PetryNatashaDr. Natasha Petry graduated with her Doctorate of Pharmacy in 2012 from North Dakota State University (NDSU) in Fargo, ND. After completing a PGY-1 Pharmacy Practice Residency at Trinity Health in Minot, ND, she joined the faculty at NDSU as an Assistant Professor with a clinical appointment at Sanford Health. Dr. Petry began working in the area of pharmacogenomics in 2014. She was an affiliate member of the NIH funded Implementing GeNomics In pracTicE (IGNITE) network and continues to build on that work with IGNITE-2. In clinical practice she performs pharmacogenetic chart reviews while her faculty position allows her to teach pharmacogenetics and other topics to pharmacy students. She has given many pharmacogenetic related CE presentations and published pharmacogenetic related articles. She has a passion for implementation of pharmacogenomics into practice as well as pharmacogenetic education initiatives for healthcare workers.


Baye_JordanJordan Baye is a clinical pharmacist at Sanford Imagenetics and Assistant Professor of pharmacy practice for the South Dakota State University College of Pharmacy and Allied Health Professions.  He graduated from the University of Iowa College of Pharmacy in 2011, completed a PGY-1 pharmacy practice residency at the Iowa City VA Health Care System in 2012, and became board certified in pharmacotherapy in 2014.  He was an inpatient pharmacist at Sanford USD Medical Center for 6 years before moving to his current position with Sanford Imagenetics.  At Imagenetics, Dr Baye's duties include clinical pharmacogenomics review and consultation, patient and provider education, and ongoing pharmacogenomics implementation. He has been integral to Sanford Health's effort to implement and expand pharmacogenomics into primary care throughout the Sanford Health enterprise. As assistant professor at the SDSU College of Pharmacy, Dr. Baye provides didactic education to PharmD students in the areas of pharmacogenomics, internal medicine, and ethics. He also directs pharmacogenomics experiential education for PharmD students on IPPE and APPE rotations and PGY-1 pharmacy practice residents at Sanford Health. Dr. Baye's research interests include pharmacogenomics outcomes research, pharmacogenomics education and practice, and pharmacy ethics. He is a member of the Clinical Pharmacogenomics Implementation Consortium.